trending Market Intelligence /marketintelligence/en/news-insights/trending/Yu56F_1yapGM8ZAfC-7Ecw2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Entellus Medical prices primary, secondary stock offering


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Entellus Medical prices primary, secondary stock offering

Entellus Medical Inc. priced an offering of 2,353,530 shares at $17 apiece to raise funds for working capital purposes, including the repayment of its credit facility.

The company also granted underwriters a 30-day option to purchase up to an additional 529,500 of the shares offered.

The offering is expected to close Jan. 31.

Meanwhile, certain Entellus shareholders also plan to sell 1,176,470 shares of the company at the same price.

BofA Merrill Lynch and Piper Jaffray & Co. are acting as joint book-running managers for the offering. William Blair is acting as co-manager.